Regulation of extracellular superoxide dismutase in human pulmonary arterial hype
细胞外超氧化物歧化酶在人肺动脉高压中的调节
基本信息
- 批准号:8210797
- 负责人:
- 金额:$ 7.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-23 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAffectAnimal ModelAntioxidantsAttenuatedAzacitidineBiologyBlood VesselsBronchiCell ProliferationCellsChildCpG IslandsCytosineDNA MethylationDataDevelopmentDiagnosisDiseaseDisease ProgressionEnzymesEpigenetic ProcessEventFibrosisFoundationsFreezingGene DeliveryGene ExpressionGene ProteinsGenesGenetic TranscriptionGenomicsGoalsGuanosineHumanHuman DevelopmentHypermethylationHypertensionInflammationInjuryLeadLifeLungLung TransplantationLung diseasesMeasuresMediatingMessenger RNAMethylationModificationMolecularNational Heart, Lung, and Blood InstituteNormal CellNucleotidesOrgan TransplantationPathogenesisPathway interactionsPatientsProcessPromoter RegionsProtein IsoformsProteinsPulmonary CirculationPulmonary HypertensionPulmonary artery structureReactive Oxygen SpeciesRegulationResearchResearch PersonnelResearch ProposalsRoleSamplingSerumSmooth Muscle MyocytesSuperoxide DismutaseSuperoxidesTestingTherapeuticTimeTissue BankingTissue BanksTissuesTransgenic MiceVascular DiseasesVascular remodelingWorkabstractingattenuationbasebisulfitecancer celldemethylationdisorder controlenzyme activityextracellularhuman diseaseimprovedinhibitor/antagonistneoplastic cellnovelnovel therapeuticspromoterprotein expressionpulmonary arterial hypertensiontool
项目摘要
DESCRIPTION (provided by applicant): Idiopathic pulmonary arterial hypertension (IPAH) is a life-threatening disease of the pulmonary circulation affecting children and adults. Accumulating evidence indicates that one key factor that contributes to the pathogenesis of vascular diseases, including PAH, is an increase in reactive oxygen species, such as superoxide (O2-), that exceed antioxidant capabilities. One critically important antioxidant in the vessel wall is extracellular superoxide dismutase (EC-SOD), the sole enzymatic defense against extracellular O2-. EC-SOD is the most highly expressed SOD isoform in the vasculature under normal conditions, and EC-SOD expression is decreased in animal models of lung or vascular injury and several human diseases, including one study showing a decrease in EC-SOD protein in the bronchus of 8 patients with IPAH. Augmenting EC- SOD activity in transgenic mice or through adenoviral gene delivery attenuates pulmonary vascular remodeling and pulmonary hypertension. The regulation of EC-SOD in IPAH has not been investigated. It is now recognized that gene expression can be regulated by epigenetic modifications including cytosine methylation within the promoter region, specifically cytosines adjacent to guanosine nucleotides (CpG islands). New data identify CpG islands within the EC-SOD promoter that can be methylated, and indicate that hypermethylation of the EC-SOD promoter inhibits EC-SOD transcription in human cancer cells, contributing to enhanced tumor cell proliferation. Based on these data, we hypothesize that DNA methylation of the EC-SOD promoter mediates silencing of this protective gene and contributes to the pathogenesis of idiopathic pulmonary arterial hypertension. Aim 1 will utilize lung and pulmonary artery tissue and serum procured at the time of organ transplantation in patients with IPAH, disease-specific controls with PAH due to other causes, or patients without PAH to determine whether EC-SOD gene and protein as well as enzyme activity are decreased in IPAH and test the impact of EC-SOD expression on pulmonary artery smooth muscle cell proliferation. Specific Aim 2 will then use bisulfite genomic sequencing to test whether the EC-SOD promoter in pulmonary artery tissue and pulmonary artery smooth muscle cells from humans with IPAH is hypermethylated, and if reversal of methylation restores EC-SOD expression and normal cell proliferation. The tissue and cell samples used in this study will have been procured and processed through the efforts of the investigators of the Pulmonary Hypertension Breakthrough Initiative. Our findings will serve as strong preliminary data for the subsequent submission of a comprehensive RO1 application investigating the regulation of EC-SOD in IPAH. The long term goals are to establish new pathways important in the regulation of this pivotal antioxidant enzyme in the vessel wall, identify the role of extracellular superoxide in proliferation, inflammation and fibrosis contributing to pulmonary vascular remodeling, and provide a rationale for novel therapeutic tools to improve treatment of this lethal disease affecting children and adults.
PUBLIC HEALTH RELEVANCE: This research proposal examines whether DNA methylation, increasingly recognized as a key epigenetic mechanism to regulate gene expression, regulates the transcription of a critically important antioxidant enzyme, extracellular superoxide dismutase, in the pulmonary artery of patients with idiopathic or familial pulmonary artery hypertension. This work will provide a strong foundation to understand the mechanisms responsible for loss of this essential antioxidant in human pulmonary arterial hypertension and provide a rationale for novel therapeutic strategies to improve treatment of this lethal disease affecting children and adults. (End of Abstract)
描述(申请人提供):特发性肺动脉高压(IPAH)是一种危及生命的肺循环疾病,影响儿童和成人。越来越多的证据表明,包括PAH在内的血管疾病发病机制中的一个关键因素是超氧化物(O2-)等活性氧物种的增加,这些氧物种超过了抗氧化能力。血管壁中一种至关重要的抗氧化剂是细胞外超氧化物歧化酶(EC-SOD),它是唯一一种防御细胞外O2-的酶。EC-SOD是正常情况下血管系统中表达最高的SOD亚型,在肺或血管损伤的动物模型和几种人类疾病中EC-SOD的表达降低,其中一项研究显示8例IPAH患者的支气管EC-SOD蛋白表达降低。在转基因小鼠中增强EC-SOD活性或通过腺病毒基因传递可以减轻肺血管重构和肺动脉高压。EC-SOD在IPAH中的调节作用尚未见报道。现在人们认识到,基因表达可以通过表观遗传修饰来调节,包括启动子区域内的胞嘧啶甲基化,特别是鸟苷核苷酸(CpG岛)附近的胞嘧啶。新的数据确定了EC-SOD启动子中可以甲基化的CpG岛,并表明EC-SOD启动子的超甲基化抑制了EC-SOD在人类癌细胞中的转录,有助于促进肿瘤细胞的增殖。基于这些数据,我们推测EC-SOD启动子的DNA甲基化介导了这一保护基因的沉默,并在特发性肺动脉高压的发病机制中发挥了作用。目的1利用肺高压患者、其他原因引起的肺高压患者和无肺高压患者在器官移植时获取的肺和肺动脉组织和血清,检测EC-SOD基因、蛋白和酶活性是否在IPAH中降低,并检测EC-SOD表达对肺动脉平滑肌细胞增殖的影响。然后,SPICAL AIM 2将使用亚硫酸氢盐基因组测序来测试患有IPAH的人的肺动脉组织和肺动脉平滑肌细胞中的EC-SOD启动子是否高甲基化,以及甲基化逆转是否恢复EC-SOD的表达和正常细胞增殖。这项研究中使用的组织和细胞样本将通过肺高压突破倡议的研究人员的努力获得和处理。我们的发现将为随后提交一份全面的RO1申请提供强有力的初步数据,该申请调查Ipah中EC-SOD的调节。长期目标是建立在调节血管壁这种关键抗氧化酶方面重要的新途径,确定细胞外超氧化物在促进肺血管重塑的增殖、炎症和纤维化中的作用,并为改进这种影响儿童和成人的致命疾病的治疗提供理论基础。
与公共健康相关:这项研究计划检查DNA甲基化是否调节特发性或家族性肺动脉高压患者的肺动脉中一种至关重要的抗氧化酶--细胞外超氧化物歧化酶的转录。DNA甲基化日益被认为是调节基因表达的关键表观遗传学机制。这项工作将为了解人类肺动脉高压中这种基本抗氧化剂丢失的机制提供坚实的基础,并为改进这种影响儿童和成人的致命疾病的治疗提供新的治疗策略的理论基础。(摘要结束)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eva S. Nozik其他文献
Nbeal2 knockout mice are not protected against hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension
Nbeal2基因敲除小鼠对缺氧诱导的肺血管重构和肺动脉高压没有保护作用
- DOI:
10.1182/bloodadvances.2024013880 - 发表时间:
2025-04-08 - 期刊:
- 影响因子:7.100
- 作者:
Janelle N. Posey;Mariah Jordan;Caitlin V. Lewis;Christina Sul;Evgenia Dobrinskikh;Delaney Swindle;Frederik Denorme;David Irwin;Jorge Di Paola;Kurt Stenmark;Eva S. Nozik;Cassidy Delaney - 通讯作者:
Cassidy Delaney
Eva S. Nozik的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eva S. Nozik', 18)}}的其他基金
R35 Administrative Supplements to Recognize Excellencein Diversity, Equity, Inclusion, and Accessibility (DEIA)Mentorship
R35 表彰多元化、公平、包容性和可及性 (DEIA) 指导方面卓越表现的行政补充
- 批准号:
10630461 - 财政年份:2022
- 资助金额:
$ 7.65万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10470946 - 财政年份:2021
- 资助金额:
$ 7.65万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10667490 - 财政年份:2021
- 资助金额:
$ 7.65万 - 项目类别:
SOD3 regulation of redox sensitive signaling in pulmonary vascular diseases
SOD3 对肺血管疾病中氧化还原敏感信号的调节
- 批准号:
10847902 - 财政年份:2018
- 资助金额:
$ 7.65万 - 项目类别:
SOD3 regulation of redox sensitive signaling in pulmonary vascular diseases
SOD3 对肺血管疾病中氧化还原敏感信号的调节
- 批准号:
10433989 - 财政年份:2018
- 资助金额:
$ 7.65万 - 项目类别:
SOD3 regulation of redox sensitive signaling in pulmonary vascular diseases
SOD3 对肺血管疾病中氧化还原敏感信号的调节
- 批准号:
10610425 - 财政年份:2018
- 资助金额:
$ 7.65万 - 项目类别:
SOD3 regulation of redox sensitive signaling in pulmonary vascular diseases
SOD3 对肺血管疾病中氧化还原敏感信号的调节
- 批准号:
10237868 - 财政年份:2018
- 资助金额:
$ 7.65万 - 项目类别:
DNA methylation of extracellular superoxide dismutase in pulmonary hypertension
肺动脉高压细胞外超氧化物歧化酶 DNA 甲基化
- 批准号:
8335465 - 财政年份:2011
- 资助金额:
$ 7.65万 - 项目类别:
Extracellular superoxide induces Egr-1 in the hypoxic pulmonary artery
细胞外超氧化物在缺氧肺动脉中诱导 Egr-1
- 批准号:
7841072 - 财政年份:2009
- 资助金额:
$ 7.65万 - 项目类别:
Extracellular superoxide induces Egr-1 in the hypoxic pulmonary artery
细胞外超氧化物在缺氧肺动脉中诱导 Egr-1
- 批准号:
8197441 - 财政年份:2007
- 资助金额:
$ 7.65万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 7.65万 - 项目类别:
Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 7.65万 - 项目类别:
Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 7.65万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 7.65万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 7.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 7.65万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




